[CCP] Announcement of Important Resolutions of the 2026 Annual General Meeting
CCP held its AGM on May 28, 2026, approving the 2026 loss compensation plan and financial statements… · 2026-05-28
中化生 News Releases
Chung-Hwa Bio: Announcement of Board Approval to Lift Non-Compete Restriction for Manager
Chung-Hwa Bio's Board of Directors approved on May 5, 2026, the lifting of the non-compete restricti… · 2026-05-05
[CSPC] Announcement of the Board of Directors Approving the Appointment of a Vice President
CSPC announced a personnel change for the Vice President of the Quality Management Center. Wang Wen-… · 2026-05-05
Zhonghua Sheng Announces Board Approval of Q1 2026 Consolidated Financial Report
Zhonghua Sheng's board and audit committee approved the Q1 2026 consolidated financial report on May… · 2026-05-05
Chung-Hwa Bio: Announcement of Board Approval to Lift Non-Compete Restriction for Manager
Chung-Hwa Bio's Board of Directors approved on May 5, 2026, the lifting of the non-compete restricti… · 2026-05-05
[CSPC] Announcement of the Board of Directors Approving the Appointment of a Vice President
CSPC announced a personnel change for the Vice President of the Quality Management Center. Wang Wen-… · 2026-05-05
Zhonghua Sheng Announces Board Approval of Q1 2026 Consolidated Financial Report
Zhonghua Sheng's board and audit committee approved the Q1 2026 consolidated financial report on May… · 2026-05-05
[CCI] May 2026 Revenue Reaches NT$ 72 Million (Down 27.2% YoY)
China Chemical Synthesis Biotech (CCI, Stock Code: 1762) announced its May 2026 revenue of NT$ 72,42… · 2026-05-01
【China Chemical & Pharmaceutical】Announcement of Board Meeting Date for Company's Q1 2026 Consolidated Financial Report Scheduled for May 5, 2026
China Chemical & Pharmaceutical announced that its board meeting to discuss the Q1 2026 consolidated… · 2026-04-27
【China Chemical & Pharmaceutical】Announcement of Board Meeting Date for Company's Q1 2026 Consolidated Financial Report Scheduled for May 5, 2026
China Chemical & Pharmaceutical announced that its board meeting to discuss the Q1 2026 consolidated… · 2026-04-27
【China Chemical & Pharmaceutical】April 2026 Monthly Revenue Reaches NT$131 Million (YoY +76.0%)
China Chemical & Pharmaceutical Co., Ltd. announced its April 2026 monthly revenue reached NT$131 mi… · 2026-04-01
【China Chemical & Pharmaceutical】April 2026 Monthly Revenue Reaches NT$131 Million (YoY +76.0%)
China Chemical & Pharmaceutical Co., Ltd. announced its April 2026 monthly revenue reached NT$131 mi… · 2026-04-01
Chung Hwa Bio: March 2026 Revenue Reaches 131 Million (Up 108.9% Year-on-Year)
Chung Hwa Bio (stock code: 1762) announced its March 2026 monthly revenue of 131.435 million JPY, a … · 2026-03-01
Chung Hwa Bio: March 2026 Revenue Reaches 131 Million (Up 108.9% Year-on-Year)
Chung Hwa Bio (stock code: 1762) announced its March 2026 monthly revenue of 131.435 million JPY, a … · 2026-03-01
[China Chemical & Pharmaceutical Co.] 2026-02 Monthly Revenue NT$103 Million (YoY +161.3%)
China Chemical & Pharmaceutical Co. (1762) announced that its February 2026 revenue reached NT$103 m… · 2026-02-01
[China Chemical & Pharmaceutical Co.] 2026-02 Monthly Revenue NT$103 Million (YoY +161.3%)
China Chemical & Pharmaceutical Co. (1762) announced that its February 2026 revenue reached NT$103 m… · 2026-02-01